Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability.

MLA

Matsumoto, Hiroaki, et al. “Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability.” Cancer Research, vol. 73, no. 16, Aug. 2013, pp. 5206–17. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-13-0359.

APA

Matsumoto, H., Yamamoto, Y., Shiota, M., Kuruma, H., Beraldi, E., Matsuyama, H., Zoubeidi, A., & Gleave, M. (2013). Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability. Cancer Research, 73(16), 5206–5217. https://doi.org/10.1158/0008-5472.CAN-13-0359

Chicago

Matsumoto, Hiroaki, Yoshiaki Yamamoto, Masaki Shiota, Hidetoshi Kuruma, Eliana Beraldi, Hideyasu Matsuyama, Amina Zoubeidi, and Martin Gleave. 2013. “Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability.” Cancer Research 73 (16): 5206–17. doi:10.1158/0008-5472.CAN-13-0359.